Research use only. All compounds are for laboratory research. Not for human or veterinary use. 21+.

NAD+, 500 mg

Lot VA-2602-9762, analysed 2026-02-16

Traceability. The analytical report behind this certificate carries no lot identifier. It covers this material at this fill weight and it names no production run, so this certificate cannot be matched to one by number. Vantage publishes it on that basis rather than implying a link the document does not print.

Results

TestSpecificationResultStatus
Appearance Visual inspection (Vantage Aminos)White lyophilized powderConformsPASS
Identity HPLC-UV-MS, positive polarity (+MS)NAD+ confirmed332.38 [M+4H]4+ · 663.93 [M+3H]3+PASS
Purity HPLC-UV, area %≥ 98.0 %99.955 %PASS
Net content As reported by the laboratoryReport (label 500 mg)518.09 mg (103.6 % of label)REPORT
Bacterial endotoxin LAL, USP <85>PassPass (duplicate, USP <85>)PASS

No chromatogram is reproduced. Vantage plots a figure only from the instrument's own exported data or one reissued by the laboratory; neither is held for this lot. Results above are transcribed from the laboratory report retained unaltered on file.

Open the certificate (PDF, opens in a new tab) Go to NAD+ All batch records

Identity and handling

Specimen readout VA-NAD-500MG
CAS
53-84-9
FORMULA
C21H27N7O14P2
MOL. WEIGHT
663.4
FORM
White lyophilized powder
FILL
500 mg
CONTAINER
3 mL vial
MANUFACTURED
2026-01-07
FILLED
2026-01-15
ANALYSED
2026-02-16
RETEST BY
2028-01-07
STORAGE
Refrigerated, 2-8 °C, protected from light
DOCUMENT
COA-VA-2602-9762 rev 1.0

Method

  • Technique HPLC-UV, area %
  • MS technique HPLC-UV-MS (as printed on the report)
  • Ionisation Positive polarity (+MS)
  • Observed mass 332.38 [M+4H]4+ · 663.93 [M+3H]3+

For research use only. Not for human or veterinary use. Not approved by the FDA. 21+